| scholarly article | Q13442814 |
| P50 | author | Steven Rosenberg | Q2347448 |
| P2093 | author name string | Eisenthal A | |
| LeFor AT | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4062-4069 | |
| P577 | publication date | 1988-06-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Heterogeneity of lymphokine-activated killer cells induced by IL-2. Separate lymphoid subpopulations lyse tumor, allogeneic blasts, and modified syngeneic blasts | |
| P478 | volume | 140 |
| Q69069333 | Auto-tumor lysis by blood lymphocytes in vitro. Strongly activated lymphocytes lack selectivity |
| Q72386246 | Combined activation of murine lymphocytes with staphylococcal enterotoxin and interleukin-2 results in additive cytotoxic activity |
| Q44079985 | Cytotoxic activity and phenotypic characteristics of lymphocyte subsets after therapy of cancer patients with interleukin-2. |
| Q72873372 | Effect of allogeneic tumor cells, interleukin-2 and interleukin-6, on the growth of subcutaneous syngeneic tumors |
| Q41700938 | Effect of culture media on lymphokine-activated killer effector phenotype and lytic capacity |
| Q69311121 | Human lymphokine-activated killer cells suppress pokeweed mitogen-induced immunoglobulin synthesis |
| Q36350708 | In vivo administration of interleukin 2 plus T cell-depleted syngeneic marrow prevents graft-versus-host disease mortality and permits alloengraftment |
| Q33707814 | Interleukin 2 prevents graft-versus-host disease while preserving the graft-versus-leukemia effect of allogeneic T cells |
| Q54333828 | Mouse tumors are heterogeneous in their susceptibility to syngeneic lymphokine-activated killer cells and delineate functional subsets in such effectors. |
Search more.